The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway

Kallikrein-related peptidase 5 (KLK5) displays aberrant expression in cancer. However, any functional association is missing. Here, we show that reconstitution of KLK5 expression in non-expressing MDA-MB-231 breast cancer cells suppresses malignancy in vitro and in vivo dose-dependently. Reactivatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pampalakis, Georgios, Obasuyi, Osahon, Papadodima, Olga, Chatziioannou, Aristotelis, Zoumpourlis, Vassileios, Sotiropoulou, Georgia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2013
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058013/
https://ncbi.nlm.nih.gov/pubmed/24158494
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia